泰州招聘

工作职责:

ROLE SUMMARY

This role will be responsible for driving Incentive Compensation (IC) service delivery activities within China that allows the business to drive quality at scale. The Incentive Compensation – China Lead role will strategically collaborate with senior business leaders, Biopharma Ops Partners (BOPs), and other Regional Leads within Incentive Compensation to operationalize key Incentive Compensation services. This includes defining and applying quotas, bonus recognition and competitions, contests, and awards for China.

The role will not be responsible for service design (e.g. innovation) but will partner closely with the Service Design Owner for Incentive Compensation as well as Bold Move Design Owners as needed to support and enable service improvements for China within this service vertical.

Key Attributes:

Accountable for leading team of colleagues to deliver Incentive Compensation remit within China meeting and exceeding expectations while enhancing service delivery continuity and quality

Responsible for the below Incentive Compensation activities in China:

Quota Definition and Application

Bonus Recognition

Competitions, Contests, and Awards

Enables Service Design Owner / Bold Moves team to implement service improvements to Incentive Compensation

Collaborates with Incentive Compensation Service Vertical Lead and other Regional Leads across to deliver strategic solutions that advance and optimize the Incentive Compensation under a globally connected, locally-embedded model

Reports to Incentive Compensation Service Vertical Lead of Biopharma Ops

ROLE RESPONSIBILTIES

Leads Incentive Compensation services in China:

Rewards Field Force colleagues by defining and applying quotas, bonus recognition and competitions, contests, and awards

Drives and oversees Incentive Compensation processes for China sales representatives

Proactively identifies potential Incentive Compensation compliance risks for China and partners with Biopharma Quality to manage these

Attracts, develops, retains, and engages a high performing virtual and in market service delivery team:

Leads the Incentive Compensation service delivery team by attracting, developing and motivating a team of <5 direct reports ; recruits and retains talented colleagues in an environment and markets wherein colleague retention will be a key challenge

Creates, maintains and demonstrates an in-depth understanding of priorities across the service delivery team and works collaboratively with the team to allocate team resources appropriately to meet service delivery commitments

Manages the high performance of the service delivery team ensuring team members are equipped with the required capabilities to perform their assigned tasks effectively

Identifies opportunities for improving Incentive Compensation service delivery within China:

Streamlines and scales systems across China and BUs with central support

Identifies needs for innovation or operational support

Drives alignment to the IC Design and Global Vertical service catalog definition, processes, enhancements and strategies

Drives transformation:  standardization, optimization and automation towards higher efficiency, better service quality, and faster solution provisioning

Ensures the collection and provision of service delivery data and insights to support further service delivery optimization, effectiveness of daily service delivery operations and to provide insight for Biopharma Ops

Ensure the usage of Biopharma Ops service delivery tools and platforms.

Improves quality, consistency (One Pfizer), and compliance across BUs and China

Ensure all service delivery meets agreed in place quality plans in collaboration with CQO and HR Global Compensation to meet compliance policies, guidelines and procedures

Partners with Regional Leads in Incentive Compensation group in defining priorities and allocating resources to drive efficient and effective HCP engagement:

Possesses a deep understanding of China business landscapes and BU strategies to determine key priorities and their impact on Incentive Compensation activities

Proactively engages with Biopharma Ops Partners (BOPs) and BU leads to understand and 1) ensure alignment of Biopharma Ops’ client strategies in China and 2) determines optimal resource al"location" and investment that enables efficient and high-quality HCP engagement

Manages his/her budget to ensure service delivery commitment and financial expectations are met

Will align, contribute to and implement the new IC Design capabilities that are part of the Vertical roadmap and strategy

QUALIFICATIONS

BA Required; MBA or equivalent Master’s-level education preferred

7+ years of commercial experience, preferably in incentive compensation work and / or in China

English proficiency preferred

Proven multi-year track record of 6 + years of team leadership experience

Cross-BU and/or diversity of job experiences

Proven track record of delivering business performance

Demonstrated history of leading innovation/transformation

Drive for optimization/excellence

Delivery of exceptional customer services and experiences

Track record for building strong cultures

Strong ability to drive collaboration and foster highly productive, functional relationships

Demonstrated agility and ability to drive program completion in expedited timelines

任职资格:

as above

辉瑞公司（Pfizer Inc.）创建于1849年，迄今已有160多年的历史，总部位于美国纽约，是目前全球***的以研发为基础的生物制药公司。辉瑞致力于运用创新的科学技术以及全球资源来改善每个生命阶段的健康和福祉。
我们的目标是“不断创新为患者带来能显著改善其健康的药物”。我们的使命是“成为一家卓越的创新型生物制药公司”。
2012年辉瑞公司全年合计收入590亿美元，研发投入78亿美元。辉瑞在全球拥有9万多名员工，59家生产基地，业务遍及全球150多个国家和地区。2012年财富全球500强企业中辉瑞排名126位。
目前辉瑞公司的产品覆盖了包括化学药物、生物制剂、疫苗、健康药物、动物保健品等用于人类、动物和消费者保健等诸多广泛而极具潜力的治疗及健康领域，同时其卓越的研发和生产能力处于全球领先地位。
在人类和动物药品的发现、开发和生产过程中，辉瑞始终致力于奉行严格的质量、安全和价值标准。每天，分布在世界各地的辉瑞员工致力于促进当地医疗卫生的发展以及探索能够应对当今最为棘手疾病的预防和治疗方案。
辉瑞还与世界各地的医疗卫生专业人士、政府和社区合作，支持世界各地的人们能够获得更为可靠和可承付的医疗卫生服务。这与辉瑞作为一家世界领先的生物制药公司的责任是一致的。160多年来，辉瑞一直努力为人们提供更好、更优质的服务。
辉瑞生物制药目前在华上市的创新药物已超过50个，其治疗领域涵盖了心脑血管及代谢、抗感染、中枢神经、抗炎镇痛、抗肿瘤、泌尿、疫苗及等诸多领域。其中如立普妥®、络活喜®、万艾可®、舒普深®、希舒美®、沛儿®、索坦®许多产品在市场上处于领先地位。为了让中国的广大患者能及时接受与全球同步的先进的药物治疗，辉瑞未来将进一步加大和加快在华新药引进和上市的力度和速度。
辉瑞健康药物旗下的善存®、钙尔奇®、惠菲宁®等消费保健产品也在中国市场家喻户晓，并以其优异的品质深受广大消费者的青睐；辉瑞旗下的硕腾动物保健品*为中国的动物保健市场提供各类领先的动物疫苗和动物药品。

At Pfizer, we apply science and our global resources to improve health and well-being at every stage of life. We strive to set the standard for quality, safety and value in the discovery, development and manufacturing of medicines for people and animals. Our diversified global health care portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products of healthcare industry and many of the world's best-known healthcare products such as Centrum. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as the world's leading biopharmaceutical company, we also collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 160 years, Pfizer has worked to make a difference for all who rely on us.